US-listed company Sonnet BioTherapeutics postpones merger vote to December 2
Show original
Foresight News reported that the US-listed company Sonnet BioTherapeutics has postponed its merger vote to December 2. Previously, it was reported that Sonnet BioTherapeutics would merge with Rorschach I LLC to form Hyperliquid Strategies and advance the HYPE reserve strategy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Vitalik calls for the Ethereum base layer to "ossify", urging innovation to shift to the L2 ecosystem
Chaincatcher•2025/11/19 02:40
Data: BTC short-term holders capitulate, on-chain data shows panic selling is nearing its end
Chaincatcher•2025/11/19 02:05
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$92,440.44
+2.16%
Ethereum
ETH
$3,110.44
+4.83%
Tether USDt
USDT
$0.9995
+0.06%
XRP
XRP
$2.21
+4.13%
BNB
BNB
$938.07
+4.69%
Solana
SOL
$142.05
+6.98%
USDC
USDC
$0.9996
-0.01%
TRON
TRX
$0.2896
+0.04%
Dogecoin
DOGE
$0.1611
+6.30%
Cardano
ADA
$0.4744
+3.14%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now